Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8561 |
Apcin
|
APC | Cell Cycle/Checkpoint |
Apcin 是后期促进复合物/环体 (APC/C(Cdc20)) E3 连接酶活性的有效竞争性抑制剂,可通过与 Cdc20 结合并阻止底物识别竞争性地抑制 APC/C 依赖性泛素化。它占据 WD40 结构域侧面的 D-box 结合口袋,并可以延长有丝分裂。它通过阻断有丝分裂退出并通过共同添加 Ts-Arg-OMe 协同放大而起作用。 | |||
TP1628L |
Activated Protein C (390-404), human acetate
Activated Protein C (390-404), human acetate(146340-20-7 Free base) |
APC | Cell Cycle/Checkpoint |
Activated Protein C (390-404), human acetate (Activated Protein C ) 抑制 APC 抗凝活性。 | |||
T1731 |
TAME hydrochloride
NA-P-甲苯磺酰-L-精氨酸甲酯盐酸盐,Tos-Arg-OMe HCl,TOS-ARG-OME hydrochloride |
Amino Acids and Derivatives; APC | Cell Cycle/Checkpoint; Metabolism |
TAME hydrochloride (Tos-Arg-OMe HCl) 是后期促进复合体(APC/C 或 APC)的抑制剂,可与 APC/C 结合并阻止其通过 Cdc20 和 Cdh1 活化,产生有丝分裂阻滞。它是一种 od 氨基酸衍生物。 | |||
T6693 |
TAME
N-[(4-甲基苯基)磺酰基]-L-精氨酸甲酯,Tosylarginine methyl ester,N-4-Tosyl-L-arginine methyl ester |
APC | Cell Cycle/Checkpoint |
TAME (N-4-Tosyl-L-arginine methyl ester) 是后期促进复合体(APC/C 或 APC)的抑制剂,可与 APC/C 结合并阻止其通过 Cdc20 和 Cdh1 活化,产生有丝分裂阻滞。 | |||
TP1196 |
D-Lys(Z)-Pro-Arg-pNA
Chromozym Pca |
||
D-Lys(Z)-Pro-Arg-pNA is a luminescent substrate of activated protein C (APC). | |||
TP1628 |
Activated Protein C (390-404), human
|
||
Activated Protein C (390-404), human, a peptide derived from the vitamin K-dependent serine protease, effectively suppresses the anticoagulant activity of APC[1]. | |||
TP1580 |
Activated Protein C (390-404), human TFA
|
||
The peptide region containing residues 390-404 in Activated Protein C (APC) is essential for anticoagulant activity and is available for interaction with antibodies or with other proteins, such as the macromolecular substrates Factors Va or VIIIa. APC reg | |||
T82526 | Drotrecogin alfa (activated) | ||
Drotrecogin alfa activated (DrotAA)为重组人活化蛋白C(APC)。该化合物能够抑制由烟雾引起的大鼠肺微血管通透性上升及促炎细胞因子IL-1β水平增加,具有抗凝血与抗炎作用,并促进纤溶过程。Drotrecogin alfa activated主要用于重症脓毒症的实验研究。 |